# FDA Inspection 1249701 - Jeffrey M. Kaplan, M.D. - September 20, 2024

Source: https://www.keypedia.com/records/fda_inspections/jeffrey-m-kaplan-md/d5bfe8a2-b8f4-4bea-b070-4708fcf5d82e
Source feed: FDA_Inspections

> FDA Inspection 1249701 for Jeffrey M. Kaplan, M.D. on September 20, 2024. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1249701
- Company Name: Jeffrey M. Kaplan, M.D.
- Inspection Date: 2024-09-20
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Bioresearch Monitoring: Human Drugs
- Product Type: Human Drugs
- Office Name: Kansas City District Office

## Related Documents

- [FDA Inspection 1249701 - 2024-09-20](https://www.keypedia.com/records/fda_inspections/jeffrey-m-kaplan-md/5b37ae88-c97c-451e-bfa3-f9167d6dcb3e)

Company: https://www.keypedia.com/companies/jeffrey-m-kaplan-md/1c63176f-581f-403e-8827-484a387e04bc

Office: https://www.keypedia.com/offices/kansas-city-district-office/cd397ab1-df4e-46f1-ab1c-0f6db9abcf79